vs
QUINSTREET, INC（QNST）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
QUINSTREET, INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.4倍（$287.8M vs $207.3M），QUINSTREET, INC净利率更高（17.4% vs -62.0%，领先79.5%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 1.9%），QUINSTREET, INC自由现金流更多（$20.7M vs $-100.8M），过去两年QUINSTREET, INC的营收复合增速更高（53.2% vs 38.0%）
QuinStreet是一家总部位于美国加利福尼亚州福斯特城的上市网络营销企业，核心业务围绕优质域名资源展开，通过收储热门域名帮助客户获取流量，实现营销增长目标。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
QNST vs RARE — 直观对比
营收规模更大
QNST
是对方的1.4倍
$207.3M
营收增速更快
RARE
高出24.0%
1.9%
净利率更高
QNST
高出79.5%
-62.0%
自由现金流更多
QNST
多$121.5M
$-100.8M
两年增速更快
QNST
近两年复合增速
38.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $287.8M | $207.3M |
| 净利润 | $50.2M | $-128.6M |
| 毛利率 | 9.6% | — |
| 营业利润率 | 0.4% | -54.7% |
| 净利率 | 17.4% | -62.0% |
| 营收同比 | 1.9% | 25.9% |
| 净利润同比 | 3342.5% | 3.5% |
| 每股收益（稀释后） | $0.87 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收QNSTRARE
| Q4 25 | $287.8M | $207.3M | ||
| Q3 25 | $285.9M | $159.9M | ||
| Q2 25 | — | $166.5M | ||
| Q1 25 | $269.8M | $139.3M | ||
| Q4 24 | $282.6M | $164.6M | ||
| Q3 24 | $279.2M | $139.5M | ||
| Q2 24 | $198.3M | $147.0M | ||
| Q1 24 | $168.6M | $108.8M |
净利润QNSTRARE
| Q4 25 | $50.2M | $-128.6M | ||
| Q3 25 | $4.5M | $-180.4M | ||
| Q2 25 | — | $-115.0M | ||
| Q1 25 | $4.4M | $-151.1M | ||
| Q4 24 | $-1.5M | $-133.2M | ||
| Q3 24 | $-1.4M | $-133.5M | ||
| Q2 24 | $-2.2M | $-131.6M | ||
| Q1 24 | $-7.0M | $-170.7M |
毛利率QNSTRARE
| Q4 25 | 9.6% | — | ||
| Q3 25 | 9.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | 8.5% | — |
营业利润率QNSTRARE
| Q4 25 | 0.4% | -54.7% | ||
| Q3 25 | 1.7% | -106.9% | ||
| Q2 25 | — | -64.8% | ||
| Q1 25 | 1.8% | -102.6% | ||
| Q4 24 | -0.5% | -74.3% | ||
| Q3 24 | -0.4% | -94.6% | ||
| Q2 24 | -0.7% | -79.1% | ||
| Q1 24 | -3.2% | -151.9% |
净利率QNSTRARE
| Q4 25 | 17.4% | -62.0% | ||
| Q3 25 | 1.6% | -112.8% | ||
| Q2 25 | — | -69.0% | ||
| Q1 25 | 1.6% | -108.5% | ||
| Q4 24 | -0.5% | -80.9% | ||
| Q3 24 | -0.5% | -95.7% | ||
| Q2 24 | -1.1% | -89.5% | ||
| Q1 24 | -4.2% | -156.8% |
每股收益（稀释后）QNSTRARE
| Q4 25 | $0.87 | $-1.28 | ||
| Q3 25 | $0.08 | $-1.81 | ||
| Q2 25 | — | $-1.17 | ||
| Q1 25 | $0.08 | $-1.57 | ||
| Q4 24 | $-0.03 | $-1.34 | ||
| Q3 24 | $-0.02 | $-1.40 | ||
| Q2 24 | $-0.04 | $-1.52 | ||
| Q1 24 | $-0.13 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $107.0M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $294.4M | $-80.0M |
| 总资产 | $493.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资QNSTRARE
| Q4 25 | $107.0M | $421.0M | ||
| Q3 25 | $101.3M | $202.5M | ||
| Q2 25 | — | $176.3M | ||
| Q1 25 | $81.8M | $127.1M | ||
| Q4 24 | $57.8M | $174.0M | ||
| Q3 24 | $25.0M | $150.6M | ||
| Q2 24 | $50.5M | $480.7M | ||
| Q1 24 | $39.6M | $112.3M |
股东权益QNSTRARE
| Q4 25 | $294.4M | $-80.0M | ||
| Q3 25 | $246.7M | $9.2M | ||
| Q2 25 | — | $151.3M | ||
| Q1 25 | $235.5M | $144.2M | ||
| Q4 24 | $224.3M | $255.0M | ||
| Q3 24 | $219.8M | $346.8M | ||
| Q2 24 | $216.8M | $432.4M | ||
| Q1 24 | $215.0M | $140.3M |
总资产QNSTRARE
| Q4 25 | $493.0M | $1.5B | ||
| Q3 25 | $442.6M | $1.2B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | $417.2M | $1.3B | ||
| Q4 24 | $409.6M | $1.5B | ||
| Q3 24 | $401.2M | $1.5B | ||
| Q2 24 | $368.5M | $1.6B | ||
| Q1 24 | $349.3M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.6M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $20.7M | $-100.8M |
| 自由现金流率自由现金流/营收 | 7.2% | -48.6% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.43× | — |
| 过去12个月自由现金流最近4个季度 | $106.9M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流QNSTRARE
| Q4 25 | $21.6M | $-99.8M | ||
| Q3 25 | $19.6M | $-91.4M | ||
| Q2 25 | — | $-108.3M | ||
| Q1 25 | $30.1M | $-166.5M | ||
| Q4 24 | $38.7M | $-79.3M | ||
| Q3 24 | $-13.7M | $-67.0M | ||
| Q2 24 | $16.6M | $-77.0M | ||
| Q1 24 | $4.1M | $-190.7M |
自由现金流QNSTRARE
| Q4 25 | $20.7M | $-100.8M | ||
| Q3 25 | $18.4M | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | $29.5M | $-167.8M | ||
| Q4 24 | $38.2M | $-79.5M | ||
| Q3 24 | $-14.1M | $-68.6M | ||
| Q2 24 | $15.4M | $-79.0M | ||
| Q1 24 | $2.9M | $-193.9M |
自由现金流率QNSTRARE
| Q4 25 | 7.2% | -48.6% | ||
| Q3 25 | 6.4% | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | 10.9% | -120.5% | ||
| Q4 24 | 13.5% | -48.3% | ||
| Q3 24 | -5.1% | -49.2% | ||
| Q2 24 | 7.8% | -53.7% | ||
| Q1 24 | 1.7% | -178.2% |
资本支出强度QNSTRARE
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.4% | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | 0.2% | 1.0% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.2% | 1.2% | ||
| Q2 24 | 0.6% | 1.4% | ||
| Q1 24 | 0.7% | 3.0% |
现金转化率QNSTRARE
| Q4 25 | 0.43× | — | ||
| Q3 25 | 4.32× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 6.82× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
QNST
| Financial Service | $216.8M | 75% |
| Home Services And Other Revenue | $71.0M | 25% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
